The University of Southampton
University of Southampton Institutional Repository

Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

Background: Diabetes, particularly type 1 diabetes, at younger ages can be a largely preventable cause of death with the correct health care and services. We aimed to evaluate diabetes mortality and trends at ages younger than 25 years globally using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Methods: We used estimates of GBD 2019 to calculate international diabetes mortality at ages younger than 25 years in 1990 and 2019. Data sources for causes of death were obtained from vital registration systems, verbal autopsies, and other surveillance systems for 1990–2019. We estimated death rates for each location using the GBD Cause of Death Ensemble model. We analysed the association of age-standardised death rates per 100 000 population with the Socio-demographic Index (SDI) and a measure of universal health coverage (UHC) and described the variability within SDI quintiles. We present estimates with their 95% uncertainty intervals. Findings: In 2019, 16 300 (95% uncertainty interval 14 200 to 18 900) global deaths due to diabetes (type 1 and 2 combined) occurred in people younger than 25 years and 73·7% (68·3 to 77·4) were classified as due to type 1 diabetes. The age-standardised death rate was 0·50 (0·44 to 0·58) per 100 000 population, and 15 900 (97·5%) of these deaths occurred in low to high-middle SDI countries. The rate was 0·13 (0·12 to 0·14) per 100 000 population in the high SDI quintile, 0·60 (0·51 to 0·70) per 100 000 population in the low-middle SDI quintile, and 0·71 (0·60 to 0·86) per 100 000 population in the low SDI quintile. Within SDI quintiles, we observed large variability in rates across countries, in part explained by the extent of UHC (r2=0·62). From 1990 to 2019, age-standardised death rates decreased globally by 17·0% (−28·4 to −2·9) for all diabetes, and by 21·0% (–33·0 to −5·9) when considering only type 1 diabetes. However, the low SDI quintile had the lowest decline for both all diabetes (−13·6% [–28·4 to 3·4]) and for type 1 diabetes (−13·6% [–29·3 to 8·9]). Interpretation: Decreasing diabetes mortality at ages younger than 25 years remains an important challenge, especially in low and low-middle SDI countries. Inadequate diagnosis and treatment of diabetes is likely to be major contributor to these early deaths, highlighting the urgent need to provide better access to insulin and basic diabetes education and care. This mortality metric, derived from readily available and frequently updated GBD data, can help to monitor preventable diabetes-related deaths over time globally, aligned with the UN's Sustainable Development Targets, and serve as an indicator of the adequacy of basic diabetes care for type 1 and type 2 diabetes across nations. Funding: Bill & Melinda Gates Foundation.

2213-8587
177-192
Cousin, Ewerton
6b0fbb0d-350c-4ab3-b32d-a6d388b0d428
Duncan, Bruce B.
470bc848-22c7-414a-8f07-6f54d894abe8
Stein, Caroline
c61f5ca2-67d8-4d77-9e67-2020fdca7635
Ong, Kanyin Liane
92828e1b-c600-4a32-87fb-6008f49bf7f0
Vos, Theo
0ee6cce8-2193-4e42-911f-8ff254829894
Abbafati, Cristiana
521168a7-4836-42f0-b082-7b21c8093724
Abbasi-Kangevari, Mohsen
6605d315-6856-461b-a501-4a38e4ab9918
Abdelmasseh, Michael
fef7f82f-b772-477e-be64-08d4195e26fc
Abdoli, Amir
05f9f5df-b745-416c-9ddd-6f3a36379a1a
Abd-Rabu, Rami
1437731b-fff5-4c40-8a8e-97cc96608a5a
Abolhassani, Hassan
f02011b5-df85-4627-94c7-1365a4241b95
Abu-Gharbieh, Eman
213c5b0f-c0cc-4b7c-a077-35586359cf01
Accrombessi, Manfred Mario Kokou
b8f03dda-14e9-4eec-ab3a-85a7a3010d19
Adnani, Qorinah Estiningtyas Sakilah
00601077-d3be-49d0-a66d-98aa9330966e
Afzal, Muhammad Sohail
a33a030f-e401-44db-be48-797a3293cb94
Agarwal, Gina
857b681f-eb3d-44a7-8f21-1ade6a01a9cc
Agrawaal, Krishna K.
1cb2d296-1b86-4fd3-88b2-7c510bc52965
Agudelo-Botero, Marcela
bbcd0184-5968-4939-9005-45fd6b993eed
Ahinkorah, Bright Opoku
d2792456-8a95-455d-8829-a1400e3f97d0
Ahmad, Sajjad
64784a20-a375-4162-a49b-72068e55cfa0
Ahmad, Tauseef
655b560c-a5b7-4562-ace0-54e62f14685c
Ahmadi, Keivan
64f3fe5b-fdd6-42ea-9c11-75cdd1cc7775
Ahmadi, Sepideh
dc6a1563-b434-4237-9212-28b9b1661f38
Ahmadi, Ali
0a824574-c627-493a-86f7-39639b36588d
Ahmed, Ali
14689d90-3c0c-4a97-819c-dfb595ae9702
Ahmed Salih, Yusra
e2389117-034a-47d8-8d7d-a55d887a4a05
Akande-Sholabi, Wuraola
173cd358-73cf-48a6-a0fd-cf35b7015191
Akram, Tayyaba
ec4db821-f9d9-48ba-bd92-679149fe83ad
Al Hamad, Hanadi
8df27675-bf0e-434b-9335-200eacfc7445
Al-Aly, Ziyad
99c680ae-f71e-475f-90b8-736dc2333782
Alcalde-Rabanal, Jacqueline Elizabeth
89196601-be78-4675-94ac-c75b7f84b94e
Alipour, Vahid
15bceecb-2e93-4a46-886a-d2304338097f
Aljunid, Syed Mohamed
d91ecd2f-7c4b-46e3-9219-998e95e341d3
Al-Raddadi, Rajaa M.
a50b095d-1d29-4cf2-815d-56a7b1fb2730
Alvis-Guzman, Nelson
30ee5d80-26f2-4ff2-9029-79ffbea6b26f
Amini, Saeed
49db67a0-ae08-4a55-aaf1-67735ae505aa
Ancuceanu, Robert
b477d38e-6507-4202-b6fd-3a6bae6203a8
Andrei, Tudorel
37126343-85bd-4ff9-9c79-c705ffcf8a94
Andrei, Catalina Liliana
277beb63-4f1d-4848-a98a-00ec069e3051
Anjana, Ranjit Mohan
0aaec804-a814-49eb-8dea-ccc1306b20de
Ansar, Adnan
6aecde51-738e-4ec6-8724-7e54d08e0570
Antonazzo, Ippazio Cosimo
d0c0eb0c-30b3-451f-94c1-f07fca811de4
Antony, Benny
fddd6e43-a271-4476-89a2-74af9df6a12f
Anyasodor, Anayochukwu Edward
cfe81fa4-d384-44d5-893f-6fc61f804107
Arabloo, Jalal
d6981778-7e26-4fef-9f18-fd1c99cc0a8e
Arizmendi, Damian
c605379f-7e20-40b7-ae32-017baa576961
Lee, Wei Chen
4899b398-382f-430f-9c64-f164de0ced62
Li, Ming Chieh
734c0e4b-d284-491f-9cdc-ac394181bdf9
Lim, Stephen S.
99ad2619-c72c-4c23-a352-33f473f1a30f
Rahman, Md Mosfequr
e18e7868-17cf-45f3-aa90-c5b96707debe
GBD 2019 Diabetes Mortality Collaborators
Cousin, Ewerton
6b0fbb0d-350c-4ab3-b32d-a6d388b0d428
Duncan, Bruce B.
470bc848-22c7-414a-8f07-6f54d894abe8
Stein, Caroline
c61f5ca2-67d8-4d77-9e67-2020fdca7635
Ong, Kanyin Liane
92828e1b-c600-4a32-87fb-6008f49bf7f0
Vos, Theo
0ee6cce8-2193-4e42-911f-8ff254829894
Abbafati, Cristiana
521168a7-4836-42f0-b082-7b21c8093724
Abbasi-Kangevari, Mohsen
6605d315-6856-461b-a501-4a38e4ab9918
Abdelmasseh, Michael
fef7f82f-b772-477e-be64-08d4195e26fc
Abdoli, Amir
05f9f5df-b745-416c-9ddd-6f3a36379a1a
Abd-Rabu, Rami
1437731b-fff5-4c40-8a8e-97cc96608a5a
Abolhassani, Hassan
f02011b5-df85-4627-94c7-1365a4241b95
Abu-Gharbieh, Eman
213c5b0f-c0cc-4b7c-a077-35586359cf01
Accrombessi, Manfred Mario Kokou
b8f03dda-14e9-4eec-ab3a-85a7a3010d19
Adnani, Qorinah Estiningtyas Sakilah
00601077-d3be-49d0-a66d-98aa9330966e
Afzal, Muhammad Sohail
a33a030f-e401-44db-be48-797a3293cb94
Agarwal, Gina
857b681f-eb3d-44a7-8f21-1ade6a01a9cc
Agrawaal, Krishna K.
1cb2d296-1b86-4fd3-88b2-7c510bc52965
Agudelo-Botero, Marcela
bbcd0184-5968-4939-9005-45fd6b993eed
Ahinkorah, Bright Opoku
d2792456-8a95-455d-8829-a1400e3f97d0
Ahmad, Sajjad
64784a20-a375-4162-a49b-72068e55cfa0
Ahmad, Tauseef
655b560c-a5b7-4562-ace0-54e62f14685c
Ahmadi, Keivan
64f3fe5b-fdd6-42ea-9c11-75cdd1cc7775
Ahmadi, Sepideh
dc6a1563-b434-4237-9212-28b9b1661f38
Ahmadi, Ali
0a824574-c627-493a-86f7-39639b36588d
Ahmed, Ali
14689d90-3c0c-4a97-819c-dfb595ae9702
Ahmed Salih, Yusra
e2389117-034a-47d8-8d7d-a55d887a4a05
Akande-Sholabi, Wuraola
173cd358-73cf-48a6-a0fd-cf35b7015191
Akram, Tayyaba
ec4db821-f9d9-48ba-bd92-679149fe83ad
Al Hamad, Hanadi
8df27675-bf0e-434b-9335-200eacfc7445
Al-Aly, Ziyad
99c680ae-f71e-475f-90b8-736dc2333782
Alcalde-Rabanal, Jacqueline Elizabeth
89196601-be78-4675-94ac-c75b7f84b94e
Alipour, Vahid
15bceecb-2e93-4a46-886a-d2304338097f
Aljunid, Syed Mohamed
d91ecd2f-7c4b-46e3-9219-998e95e341d3
Al-Raddadi, Rajaa M.
a50b095d-1d29-4cf2-815d-56a7b1fb2730
Alvis-Guzman, Nelson
30ee5d80-26f2-4ff2-9029-79ffbea6b26f
Amini, Saeed
49db67a0-ae08-4a55-aaf1-67735ae505aa
Ancuceanu, Robert
b477d38e-6507-4202-b6fd-3a6bae6203a8
Andrei, Tudorel
37126343-85bd-4ff9-9c79-c705ffcf8a94
Andrei, Catalina Liliana
277beb63-4f1d-4848-a98a-00ec069e3051
Anjana, Ranjit Mohan
0aaec804-a814-49eb-8dea-ccc1306b20de
Ansar, Adnan
6aecde51-738e-4ec6-8724-7e54d08e0570
Antonazzo, Ippazio Cosimo
d0c0eb0c-30b3-451f-94c1-f07fca811de4
Antony, Benny
fddd6e43-a271-4476-89a2-74af9df6a12f
Anyasodor, Anayochukwu Edward
cfe81fa4-d384-44d5-893f-6fc61f804107
Arabloo, Jalal
d6981778-7e26-4fef-9f18-fd1c99cc0a8e
Arizmendi, Damian
c605379f-7e20-40b7-ae32-017baa576961
Lee, Wei Chen
4899b398-382f-430f-9c64-f164de0ced62
Li, Ming Chieh
734c0e4b-d284-491f-9cdc-ac394181bdf9
Lim, Stephen S.
99ad2619-c72c-4c23-a352-33f473f1a30f
Rahman, Md Mosfequr
e18e7868-17cf-45f3-aa90-c5b96707debe

Cousin, Ewerton, Duncan, Bruce B. and Stein, Caroline , GBD 2019 Diabetes Mortality Collaborators (2022) Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. The Lancet Diabetes and Endocrinology, 10 (3), 177-192. (doi:10.1016/S2213-8587(21)00349-1).

Record type: Article

Abstract

Background: Diabetes, particularly type 1 diabetes, at younger ages can be a largely preventable cause of death with the correct health care and services. We aimed to evaluate diabetes mortality and trends at ages younger than 25 years globally using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Methods: We used estimates of GBD 2019 to calculate international diabetes mortality at ages younger than 25 years in 1990 and 2019. Data sources for causes of death were obtained from vital registration systems, verbal autopsies, and other surveillance systems for 1990–2019. We estimated death rates for each location using the GBD Cause of Death Ensemble model. We analysed the association of age-standardised death rates per 100 000 population with the Socio-demographic Index (SDI) and a measure of universal health coverage (UHC) and described the variability within SDI quintiles. We present estimates with their 95% uncertainty intervals. Findings: In 2019, 16 300 (95% uncertainty interval 14 200 to 18 900) global deaths due to diabetes (type 1 and 2 combined) occurred in people younger than 25 years and 73·7% (68·3 to 77·4) were classified as due to type 1 diabetes. The age-standardised death rate was 0·50 (0·44 to 0·58) per 100 000 population, and 15 900 (97·5%) of these deaths occurred in low to high-middle SDI countries. The rate was 0·13 (0·12 to 0·14) per 100 000 population in the high SDI quintile, 0·60 (0·51 to 0·70) per 100 000 population in the low-middle SDI quintile, and 0·71 (0·60 to 0·86) per 100 000 population in the low SDI quintile. Within SDI quintiles, we observed large variability in rates across countries, in part explained by the extent of UHC (r2=0·62). From 1990 to 2019, age-standardised death rates decreased globally by 17·0% (−28·4 to −2·9) for all diabetes, and by 21·0% (–33·0 to −5·9) when considering only type 1 diabetes. However, the low SDI quintile had the lowest decline for both all diabetes (−13·6% [–28·4 to 3·4]) and for type 1 diabetes (−13·6% [–29·3 to 8·9]). Interpretation: Decreasing diabetes mortality at ages younger than 25 years remains an important challenge, especially in low and low-middle SDI countries. Inadequate diagnosis and treatment of diabetes is likely to be major contributor to these early deaths, highlighting the urgent need to provide better access to insulin and basic diabetes education and care. This mortality metric, derived from readily available and frequently updated GBD data, can help to monitor preventable diabetes-related deaths over time globally, aligned with the UN's Sustainable Development Targets, and serve as an indicator of the adequacy of basic diabetes care for type 1 and type 2 diabetes across nations. Funding: Bill & Melinda Gates Foundation.

Text
1-s2.0-S2213858721003491-main - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)

More information

Accepted/In Press date: 7 February 2022
e-pub ahead of print date: 21 February 2022
Published date: March 2022
Additional Information: Funding Information: J L Baker reports non-financial support as an unpaid speaker at Novo Nordisk symposiums (outside the submitted work). S Bhaskar reports institutional support from NSW Health Pathology (Australia), grants or contracts from the New South Wales (NSW) Ministry of Health NSW Brain Clot Bank (2019–22) in Australia, and paid or unpaid leadership or fiduciary roles in board, society, committee, or advocacy groups with the Rotary Club of Sydney (NSW, Australia) as a board director and chair of the Youth Committee and with the International Rotary Fellowship of Healthcare Professionals as board director (all outside the submitted work). I Y Elgendy acknowledges grants from Caladrius Biosciences, outside the submitted work. D Flood reports grants or contracts from US National Institutes of Health (NIH) funding comparative health systems research on diabetes indicators (grant P30-DK09292); unpaid leadership or fiduciary roles in board, society, committee, or advocacy groups with Maya Health Alliance as lead diabetes physician for this non-governmental clinical organisation in Guatemala, conducting unpaid advocacy on behalf of people with diabetes; and stock or stock options as co-founder and 1% co-owner of GlucoSalud, a diabetes social business in Guatemala (all outside the submitted work). N Ghith reports support for the present manuscript via a grant from the Novo Nordisk Foundation (NNF16OC0021856). N E Ismail reports an unpaid leadership or fiduciary role in board, society, committee, or advocacy group, with the Malaysian Academy of Pharmacy as a council member (outside the submitted work). K Krishan reports non-financial support from the UGC Centre of Advanced Study, CAS II, Department of Anthropology, Panjab University, Chandigarh, India (outside the submitted work). U O Mueller reports a grant from the US National Institute of Aging to the University of Washington, granted as a subaward to the Center for Population and Health, and paid or unpaid leadership or fiduciary roles in board, society, committee, or advocacy group with the Center for Population and Health as the chairman (all outside the submitted work). M P Schlaich reports grants or contracts from Boehringer Ingelheim in support for an investigator-initiated study with SGLT-2 inhibitors in patients with diabetes (outside the submitted work). J A Singh reports consulting fees from Crealta/Horizon, Medisys, Fidia, PK Med, Two Labs, Adept Field Solutions, Clinical Care Options, Clearview Healthcare Partners, Putnam Associates, FocusForward, Navigant Consulting, Spherix, MedIQ, Jupiter Life Science, UBM, Trio Health, Medscape, WebMD, Practice Point communications, the NIH, and the American College of Rheumatology; payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from Simply Speaking; support for attending meetings or travel from OMERACT, an international organisation that develops measures for clinical trials and receives arm's length funding from 12 pharmaceutical companies, when travelling to OMERACT meetings; participation on a data safety monitoring board or an advisory board as a member of the US Food and Drug Administration Arthritis Advisory Committee; paid or unpaid leadership or fiduciary roles in board, society, committee, or advocacy groups with OMERACT as a member of the steering committee, with the Veterans Affairs Rheumatology Field Advisory Committee as a chair member, and with the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis as director and editor; stock or stock options in TPT Global Tech, Vaxart Pharmaceuticals, Atyu Biopharma, and Charlotte's Web Holdings and previously owned stock options in Amarin, Viking, and Moderna pharmaceuticals (all outside the submitted work). M Tonelli reports payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing, or educational events from AstraZeneca (outside the submitted work). R Uddin reports grants from Deakin University (Geelong, VIC, Australia) through an Alfred Deakin Postdoctoral Research Fellowship and support for attending meetings or travel from the Deakin University Institute for Physical Activity and Nutrition (all outside the submitted work). S Zadey reports unpaid leadership or fiduciary roles in other board, society, committee, or advocacy groups with the Association for Socially Applicable Research as the co-founding director. Funding Information: This study is funded by the Bill & Melinda Gates Foundation. S M Aljunid acknowledges the Department of Health Policy and Management, Faculty of Public Health, Kuwait University (Kuwait City, Kuwait), and the International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia (Kuala Lumpur, Malaysia), for the approval and support to participate in this research project. T Astell-Burt was supported by a National Health and Medical Research Council (NHMRC; Australia) Boosting Dementia Research Leader Fellowship (1140317). D A Bennett is supported by the UK National Institute of Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR, or the UK Department of Health and Social Care. B Duncan and M I Schmidt were supported in part by the Brazilian National Council for Scientific and Technological Development (research fellowship), and the Institute for Health Technology Assessment (465518/2014-1). E Cousin acknowledges the Coordination for Improvement of Higher Education Personnel (Brazil). X Feng was supported by an NHMRC Career Development Fellowship (1148792). E Fernandes and M Freitas acknowledge support from Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior through national funds, and Programa Operacional Competitividade e Internacionalização (POCI-01-0145-FEDER-029241). V K Gupta and V B Gupta acknowledge funding support from the NHMRC (Australia). S Haque is grateful to the Jazan University (Jazan, Saudi Arabia), for providing the access to the Saudi Digital Library for this research study. B-F Hwang acknowledges partial support by China Medical University (Taichung, Taiwan; CMU109-MF-63). S M S Islam acknowledges funding from the National Heart Foundation of Australia and NHMRC Emerging Leadership Fellowship. M Jakovljevic acknowledges partial funding through grant OI175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. O John is a recipient of the University International Postgraduate Award scholarship from the University of New South Wales (Sydney, NSW, Australia). M N Khan acknowledges the support of the Jatiya Kabi Kazi Nazrul Islam University (Mymensingh, Bangladesh). Y J Kim was supported by Research Management Centre, Xiamen University Malaysia (Sepang, Malaysia; XMUMRF/C6/ITCM-004). B Lacey acknowledges support from the UK Biobank, University of Oxford (Oxford, UK). G Lucchetti acknowledges support from the Brazilian National Council for Scientific and Technological Development through a Research Productivity Fellowship (level 1D). L G Mantovani acknowledges support from the Italian Ministry of Health Ricerca Corrente—IRCCS MultiMedica. M Molokhia is supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London (London, UK). O O Odukoya was supported by the Fogarty International Center of the NIH under award number K43TW010704. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. N Senthil Kumar acknowledges the Department of Biotechnology (New Delhi, India) for the Advanced State Biotech Hub. S Xu was supported by grants from National Natural Science Foundation of China (grant number 82070464) and Anhui Provincial Key Research and Development Program (grant number 202104j07020051). X Xu is supported by the Heart Foundation Post-doctoral Fellowship funded by the Heart Foundation of Australia, and Scientia Program at the University of New South Wales. S B Zaman received a scholarship from the Australian Government Research Training Program in support of his academic career. Editorial note: the Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations. Funding Information: This study is funded by the Bill & Melinda Gates Foundation. S M Aljunid acknowledges the Department of Health Policy and Management, Faculty of Public Health, Kuwait University (Kuwait City, Kuwait), and the International Centre for Casemix and Clinical Coding, Faculty of Medicine, National University of Malaysia (Kuala Lumpur, Malaysia), for the approval and support to participate in this research project. T Astell-Burt was supported by a National Health and Medical Research Council (NHMRC; Australia) Boosting Dementia Research Leader Fellowship (1140317). D A Bennett is supported by the UK National Institute of Health Research (NIHR) Oxford Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service (NHS), the NIHR, or the UK Department of Health and Social Care. B Duncan and M I Schmidt were supported in part by the Brazilian National Council for Scientific and Technological Development (research fellowship), and the Institute for Health Technology Assessment (465518/2014-1). E Cousin acknowledges the Coordination for Improvement of Higher Education Personnel (Brazil). X Feng was supported by an NHMRC Career Development Fellowship (1148792). E Fernandes and M Freitas acknowledge support from Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior through national funds, and Programa Operacional Competitividade e Internacionalização (POCI-01-0145-FEDER-029241). V K Gupta and V B Gupta acknowledge funding support from the NHMRC (Australia). S Haque is grateful to the Jazan University (Jazan, Saudi Arabia), for providing the access to the Saudi Digital Library for this research study. B-F Hwang acknowledges partial support by China Medical University (Taichung, Taiwan; CMU109-MF-63). S M S Islam acknowledges funding from the National Heart Foundation of Australia and NHMRC Emerging Leadership Fellowship. M Jakovljevic acknowledges partial funding through grant OI175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. O John is a recipient of the University International Postgraduate Award scholarship from the University of New South Wales (Sydney, NSW, Australia). M N Khan acknowledges the support of the Jatiya Kabi Kazi Nazrul Islam University (Mymensingh, Bangladesh). Y J Kim was supported by Research Management Centre, Xiamen University Malaysia (Sepang, Malaysia; XMUMRF/C6/ITCM-004). B Lacey acknowledges support from the UK Biobank, University of Oxford (Oxford, UK). G Lucchetti acknowledges support from the Brazilian National Council for Scientific and Technological Development through a Research Productivity Fellowship (level 1D). L G Mantovani acknowledges support from the Italian Ministry of Health Ricerca Corrente—IRCCS MultiMedica. M Molokhia is supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London (London, UK). O O Odukoya was supported by the Fogarty International Center of the NIH under award number K43TW010704. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. N Senthil Kumar acknowledges the Department of Biotechnology (New Delhi, India) for the Advanced State Biotech Hub. S Xu was supported by grants from National Natural Science Foundation of China (grant number 82070464) and Anhui Provincial Key Research and Development Program (grant number 202104j07020051). X Xu is supported by the Heart Foundation Post-doctoral Fellowship funded by the Heart Foundation of Australia, and Scientia Program at the University of New South Wales. S B Zaman received a scholarship from the Australian Government Research Training Program in support of his academic career. Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

Identifiers

Local EPrints ID: 471835
URI: http://eprints.soton.ac.uk/id/eprint/471835
ISSN: 2213-8587
PURE UUID: 1330b3f4-40ac-4a2e-9500-2fc95c7a6fb6

Catalogue record

Date deposited: 21 Nov 2022 17:54
Last modified: 17 Mar 2024 13:09

Export record

Altmetrics

Contributors

Author: Ewerton Cousin
Author: Bruce B. Duncan
Author: Caroline Stein
Author: Kanyin Liane Ong
Author: Theo Vos
Author: Cristiana Abbafati
Author: Mohsen Abbasi-Kangevari
Author: Michael Abdelmasseh
Author: Amir Abdoli
Author: Rami Abd-Rabu
Author: Hassan Abolhassani
Author: Eman Abu-Gharbieh
Author: Manfred Mario Kokou Accrombessi
Author: Qorinah Estiningtyas Sakilah Adnani
Author: Muhammad Sohail Afzal
Author: Gina Agarwal
Author: Krishna K. Agrawaal
Author: Marcela Agudelo-Botero
Author: Bright Opoku Ahinkorah
Author: Sajjad Ahmad
Author: Tauseef Ahmad
Author: Keivan Ahmadi
Author: Sepideh Ahmadi
Author: Ali Ahmadi
Author: Ali Ahmed
Author: Yusra Ahmed Salih
Author: Wuraola Akande-Sholabi
Author: Tayyaba Akram
Author: Hanadi Al Hamad
Author: Ziyad Al-Aly
Author: Jacqueline Elizabeth Alcalde-Rabanal
Author: Vahid Alipour
Author: Syed Mohamed Aljunid
Author: Rajaa M. Al-Raddadi
Author: Nelson Alvis-Guzman
Author: Saeed Amini
Author: Robert Ancuceanu
Author: Tudorel Andrei
Author: Catalina Liliana Andrei
Author: Ranjit Mohan Anjana
Author: Adnan Ansar
Author: Ippazio Cosimo Antonazzo
Author: Benny Antony
Author: Anayochukwu Edward Anyasodor
Author: Jalal Arabloo
Author: Damian Arizmendi
Author: Wei Chen Lee
Author: Ming Chieh Li
Author: Stephen S. Lim
Author: Md Mosfequr Rahman
Corporate Author: GBD 2019 Diabetes Mortality Collaborators

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×